-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Infants (<1 year)
-
Adolescents (12-17 years)
-
Children (1-11 years)
-
Hospital
-
Outpatient clinic
-
Intensive care unit
-
SARS-CoV-2
-
Acute COVID-19
-
Blood sample
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post-COVID-19
-
Pharmacological intervention
-
Probiotic
-
Adults (18-64 years)
-
Fragile population
-
Immunocompromised host
-
People living with HIV
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Pharmacological intervention
-
Probiotic
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
Fragile population
-
Immunocompromised host
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Acute COVID-19
-
Non pharmacological intervention
-
Convalescent plasma
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Infants (<1 year)
-
Adolescents (12-17 years)
-
Children (1-11 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post-COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post-COVID-19
-
Pharmacological intervention
-
Antivirals
-
Plitidepsin